Nicotine therapeutic benefits: Difference between revisions
| Line 558: | Line 558: | ||
*[https://physoc.onlinelibrary.wiley.com/doi/pdf/10.1113/expphysiol.2006.033373 PDF Version] | *[https://physoc.onlinelibrary.wiley.com/doi/pdf/10.1113/expphysiol.2006.033373 PDF Version] | ||
*Mündel, T. and Jones, D.A. (2006), Effect of transdermal nicotine administration on exercise endurance in men. Experimental Physiology, 91: 705-713. doi: 10.1113/expphysiol.2006.033373 | *Mündel, T. and Jones, D.A. (2006), Effect of transdermal nicotine administration on exercise endurance in men. Experimental Physiology, 91: 705-713. doi: 10.1113/expphysiol.2006.033373 | ||
<br> | |||
='''Eyes - Ocular'''= | |||
==Myopia (short-sighted)== | |||
===2024: [https://iovs.arvojournals.org/article.aspx?articleid=2800816 Administration of Nicotine Can Inhibit Myopic Growth in Animal Models]=== | |||
*Nicotine, administered as an intravitreal injection or topical eye drop, significantly inhibits the development of experimental myopia. | |||
<br> | <br> | ||